B CELLS RESISTANT TO CD20 MONOCLONAL ANTIBODIES DISPLAY SPECIFIC ALTERATIONS IN GENE EXPRESSION PROFILE

EHA Library, Aneta Ledererova, 182479

DIFFERENTIAL EXPRESSION PATTERNS OF CHEMOKINE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Eva Kriegová, 182480

RESIDUAL SERUM CONCENTRATIONS OF RITUXIMAB ARE ASSOCIATED WITH RELAPSE RISK IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Adrian Tempescul, 182481

ACTIVITY OF THE CD19 ANTIBODY MOR208 IN COMBINATION WITH IBRUTINIB, IDELALISIB OR VENETOCLAX IN VITRO

EHA Library, Rainer Boxhammer, 182482

LYMPHOCYTE EXHAUSTION AND THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA - FRIENDS OR FOES?

EHA Library, Ewelina Grywalska, 182483

HSP70 AND HSF1 GO HAND IN HAND AND HAVE A ROLE IN THE SURVIVAL OF CHRONIC LYMPHOCYTIC LEUKEMIA NEOPLASTIC B CELLS.

EHA Library, Livio Trentin, 182484

OVEREXPRESSION OF GENE FOR HUMAN CONCENTRATIVE NUCLEOSIDE TRANSPORTER 3 IS A PREDICTOR OF RESISTANCE TO FLUDARABIN-BASED CHEMOTHERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Vojin Vukovic, 182485

THE SPECTRUM OF TP53, SF3B1, AND NOTCH1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS EXPOSED TO IONIZING RADIATION DUE TO THE CHORNOBYL NPP ACCIDENT

EHA Library, Nadiia Bilous, 182486

DRUG SENSITIVITY SCREENING IN CHRONIC LYMPHATIC LEUKEMIA (CLL) AND MULTIPLE MYELOMA (MM) FOR PERSONALIZED CANCER THERAPY.

EHA Library, Deepak balaji Thimiri Govinda Raj, 182487

FCGR2A AND FCGR3A VARIANTS ARE NOT ASSOCIATED WITH RESPONSE TO RITUXIMAB IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Marica Pavkovic, 182488

MUTATIONAL STATUS, IMMUNOGLOBULIN HEAVY VARIABLE (IGHV) GENES PATTERN AND STEREOTYPED RECEPTORS REPERTOIRE OF MACEDONIAN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS

EHA Library, Irina Panovska, 182489

LAMBDA LIGHT CHAIN RESTRICTION - USEFUL FOR HAIRY CELL LEUKEMIA PROGNOSTICATION?

EHA Library, Joana LIMA ARAUJO, 182490

CLINICAL EFFICACY AND LONG-TERM OUTCOMES OF SPLENECTOMY IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Maksym Semerak, 182491

MONOCLONAL B-CELL LYMPHOCYTOSIS IN THAI POPULATION: PREVALENCE AND IMMONOPHENOTYPIC CHARACTERISTICS

EHA Library, Piyanuch Kongtim, 182492

SPONTANEOUS CLINICAL REGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA: CLINICAL AND BIOLOGIC FEATURES OF 9 CASES FROM THE ERIC REGISTRY

EHA Library, Ilaria Del Giudice, 182493

CLINICAL AND LABORATORY CHARACTERIZATION OF PLATELET DYSFUNCTION DURING IBRUTINIB TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. MONOCENTRIC EXPERIENCE.

EHA Library, Idanna Innocenti, 182494

HAIRY CELL LEUKEMIA :A SUMMARY OF CLINICAL DATA ON 202 PATIENTS AND THE RESULTS OF THERAPY WITH CLADRIBINE IN ISRAEL

EHA Library, Tamar Tadmor, 182495

CHRONIC LYMPHOCYTIC LEUKEMIA: CHANGES IN CLINICAL STAGE DISCRIMINATE PATIENTS WITH DIFFERENT OUTCOME WITHIN THE IWCLL PARTIAL RESPONSE CATEGORY.

EHA Library, Eva Puy Vicente, 182496

INCIDENCE OF THYROID GLAND DISORDERS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, ANIL TOMBAK, 182497

CLINICAL-BIOLOGICAL CHARACTERISTICS, TREATMENT OUTCOME AND SURVIVAL OF SMALL LYMPHOCYTIC LYMPHOMA (SLL) PATIENTS: A REAL-LIFE EXPERIENCE

EHA Library, Sotirios Sachanas, 182498

HEMINSIGHT TO ASSESS PATIENT REPORTED OUTCOMES OF PATIENTS AFFECTED BY CHRONIC LYMPHOCYTIC LEUKEMIA IN DAILY CLINICAL PRACTICE

EHA Library, Bruno Fattizzo, 182499

HEALTHCARE COST OF MEDICARE PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Carolina Reyes, 182500

THE ROLE OF MAINTENANCE THERAPY IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Aleksei Kuvshinov, 182501

MULTISITE PERFORMANCE EVALUATION STUDY OF THE BD ONEFLOW LYMPHOID SCREENING TUBE (LST)

EHA Library, Balaji Balasa, 182502

IMMUNOGLOBULIN HEAVY/LIGHT CHAIN ASSAY DETECT IMMUNE DYSREGULATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Tamar Tadmor, 182503

INFLUENCE OF TREATMENT ON CONCENTRATION OF CYTOKINES IN BLOOD OF PATIENTS WITH HAIRY CELL LEUKEMIA

EHA Library, Nataliya Pelenyo, 182504

PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) - CLINICAL BENEFITS OF ACHIEVING A DEEP RESPONSE TO FIRST-LINE THERAPY

EHA Library, Jennifer Samp, 182505

ANTI-CD ANTIBODY MICROARRAY FOR MORPHOLOGY EXAMINATION OF CIRCULATING LEUKEMIA AND LYMPHOMA CELLS

EHA Library, Sofya Kuznetsova, 182506

COMPARATIVE ANALYSIS OF INTERNATIONAL PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKEMIA, PROGRESSION-RISK SCORE AND MD ANDERSON CANCER CENTER 2011 SCORE: REAL WORLD DATA FROM A SINGLE INSTITUTION

EHA Library, Vojin Vukovic, 182507

MULTISITE PERFORMANCE EVALUATION STUDY OF THE BD ONEFLOW B-CELL CHRONIC LYMPHOPROLIFERATIVE DISORDERS T1 (B-CLPD T1) PANEL

EHA Library, Balaji Balasa, 182508

COMBINED PATTERNS OF IGHV REPERTOIRE AND MOLECULAR ALTERATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA- SINGLE CENTER EXPERIENCE

EHA Library, S.T. Trajkova, 182509

PROGNOSTIC SIGNIFICANCE OF SERUM BAFF, APRIL, TACI AND BCMA LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ilay Berke mentese, 182510

EXPERIENCE OF IBRUTINIB IN RELAPSED/REFRACTORY B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA AND MANTLE CELL LYMPHOMA IN A U.K. DISTRICT GENERAL HOSPITAL

EHA Library, adrian smith, 182511

THE VALUE OF RITUXIMAB ADDITION TO CHEMOTHERAPY TREATMENT OF REAL-WORLD CLL PATIENTS: A 15 YEAR SINGLE CENTER EXPERIENCE

EHA Library, Lina Van Der Straten, 182512

RICHTER SYNDROME: SERBIAN LYMPHOMA GROUP EXPERIENCE

EHA Library, Vojin Vukovic, 182513

INFECTIOUS COMPLICATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA TREATED WITH IBRUTINIB

EHA Library, Ewa Wasik-Szczepaanek, 182514

MONOCLONAL B-CELL LYMPHOCYTOSIS (MBL) AND PROSTATE CANCER: AN UNEXPECTED, POSSIBLE ASSOCIATION

EHA Library, Fiorella D'auria, 182515

IDENTIFICATION OF NOVEL MUTATIONS IN CANCER-RELATED GENES IN HUMAN ERYTHROLEUKEMIA K562 CELL LINE BY NEXT-GENERATION SEQUENCING

EHA Library, Monika Pepek, 182516

INVESTIGATION OF POLYMORPHISMS RELATED TO MIR-608 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Ildar Minniakhmetov, 182517

TARGETED STRATEGY FOR ABL TYROSINE KINASE INHIBITOR RESISTANT PHILADELPHIA CHROMOSOME POSITIVE LEUKEMIA CELLS

EHA Library, Seiichi Okabe, 182518

FLUORESCENCE IN SITU HYBRIDIZATION SIGNAL PATTERNS AND INTRACHROMOSOMAL BCR-ABL1 AMPLIFICATION ANALYSIS IN IMATINIB-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA PATIENTS USING TRICOLOR DUAL FUSION PROBE.

EHA Library, Karthik Bommannan, 182519

ARE YOU ACTUALLY SUSPECTING A CHRONIC MYELOID LEUKEMIA WHEN ORDERING A BCR/ABL RT-PCR?

EHA Library, Carolina Guilen Rienda, 182520

BCR-ABL DEL. C.1086-1270 (P.R362FS*21) AND TKI RESISTANCE IN CML PATIENTS FROM RUSSIAN FEDERATION

EHA Library, Adhamjon Abdullaev, 182521

PEROXIREDOXIN II ACTIVITY HAS IMPORTANT ROLES TO CONTROL ABL TYROSINE KINASE ACTIVITY IN STIS TREATED CML PATIENTS AND ITS POTENTIAL APPLICATION IN IMATINIB RESISTANCE

EHA Library, Eun Sun Yoo, 182522

FUNCTIONAL CHARACTERISTICS OF ERYTHROID PROGENITOR CELLS OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB AND NILOTINIB

EHA Library, Tetiana Perekhrestenko, 182523

DEVELOPMENT OF FRAGMENT ANALYSIS MULTIPLEX-PCR METHOD TO DETECT TRANSCRIPTS OF BCR-ABL FUSION GENE IN CHRONIC MYELOID LEUKEMIA

EHA Library, Laura Reguilon, 182524

PDGF AND BDNF PLASMA LEVELS IN CML PATIENTS BEFORE AND AFTER INITIATION OF TKI THERAPY

EHA Library, Zofia Ulańczyk, 182526

A CASE OF ATYPICAL CHRONIC MYELOID LEUKEMIA WITH LATE DISCOVERY OF JAK2

EHA Library, Liliana Vila, 182527

E14A2 TRANSCRIPT IS ASSOCIATED WITH HIGHER PROBABILITY OF DURABLE TREATMENT FREE REMISSION IN CML PATIENTS

EHA Library, Mariella d adda, 182528

COMPARATIVE ANALYSES OF NILOTINIB VS HIGH-DOSE IMATIB VS SUSTAINING STANDARD-DOSE IMATINIB IN PATIENTS WITH CP CHRONIC MYELOID LEUKEMIA FOLLOWING SUBOPTIMAL MOLECULAR RESPONSE TO FIRST-LINE IMATINIB

EHA Library, Sung-Eun Lee, 182529

COMPARATIVE ANALYSIS OF PULMONARY HYPERTENSION IN THE 105 CML PATIENTS TREATED WITH IMATINIB, NILOTINIB AND DASATINIB

EHA Library, Mariko Minami, 182530

DYNAMICS OF BCR-ABL1 MUTATION ACQUISITION AND LONG-TIME MUTATION ASSOCIATED RESISTANCE PROGNOSIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED BY TYROSINE KINASE INHIBITORS: RUSSIA, 2006-2016

EHA Library, Vera Tikhonova, 182531

IMPACT OF BCR-ABL1 TRANSCRIPT TYPE IN CHRONIC MYELOID LEUKEMIA TREATED FRONTLINE WITH NILOTINIB

EHA Library, Fausto Castagnetti, 182532

IMATINIB (IM) 400MG IN PATIENTS WITH CML1ST CP RESULTS IN A HIGHER MOLECULAR RESPONSE RATE AT 6 MONTHS COMPARED TO IM/ HYDROXYUREA. FINAL RESULTS OF THE CML2004 STUDY. NCT 02480608.

EHA Library, Thoralf Lange, 182533

A MULTICENTER, OBSERVATIONAL, AMBISPECTIVE STUDY EVALUATING EFFICACY AND SAFETY OF GENERIC IMATINIB COMPARED TO GLEEVEC IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - 3 MONTHS RESPONSE ANALYSIS

EHA Library, Katia Pagnano, 182534

COMPLEX ADDITIONAL CHROMOSOME ABERRATIONS IN PH-POSITIVE CELLS IMPACT ON CHRONIC MYELOID LEUKEMIA PATIENTS’ SURVIVAL IN THE ERA OF TYROSINE KINASE INHIBITORS

EHA Library, Aleksandr Fomin, 182535

BCR/ABL1 TRANSCRIPT E13A2 IS ASSOCIATED WITH HIGHER CUMULATIVE PROBABILITY OF LOSS OF MAJOR MOLECULAR RESPONSE IN CML PATIENTS TREATED WITH NILOTINIB AS THE 2-ND LINE THERAPY

EHA Library, Iryna Dmytrenko, 182536

ANALYSIS OF GENERIC IMATINIB EFFICACY IN CHRONIC MYELOID LEUKEMIA TREATMENT: MORE THAN FOUR YEARS OF EXPERIENCE IN SOUTHERN SERBIA

EHA Library, Cojbasic Irena, 182537

ACHIEVING OPTIMAL RESPONSE AT 12 MONTHS IS ASSOCIATED WITH A BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A PROSPECTIVE, LONGITUDINAL, SINGLE CENTER STUDY

EHA Library, Jiang Qian, 182538

MULTI-COUNTRY RETROSPECTIVE CHART AUDIT STUDY TO EXAMINE DEEP MOLECULAR RESPONSE (MR4.5) ASSOCIATED WITH SECOND-LINE TYROSINE KINASE INHIBITORS IN CHRONIC PHASE - CHRONIC MYELOGENOUS LEUKEMIA (CML-CP)

EHA Library, Jorge Cortes, 182539

COMPUTATIONALLY INTELLIGENT PREDICTION OF CLINICAL OUTCOME IN CHRONIC MYELOID LEUKEMIA

EHA Library, Cojbasic Irena, 182540

A NATIONWIDE OBSERVATIONAL STUDY OF PONATINIB IN CHRONIC MYELOCYTIC LEUKEMIA OUTSIDE CLINICAL TRIALS.

EHA Library, Adi Abulafia, 182541

MOLECULAR RESPONSE TO THERAPY WITH TYROSINE KINASE INHIBITORS IN PATIENTS WITH BCR-ABL1(+) CHRONIC MYELOID LEUKEMIA PRESENTING WITH AN ISOLATED THROMBOCYTOSIS AT THE ONSET

EHA Library, Gueorgui Balatzenko, 182542

BCR-ABL1 MOLECULAR RESPONSES AT 12-18 MONTHS USING THE QUANTIDEX QPCR BCR-ABL1 IS KIT PREDICT LONG-TERM EVENT-FREE SURVIVAL IN PATIENTS WITH TKI-TREATED CML

EHA Library, Justin Brown, 182543

SHOULD SWITCHING TO SECOND GENERATION TKIS BE A RULE IN PATIENTS WITH CP-CML AFTER 3-6 MONTHS OF IMATINIB TREATMENT: RETROSPECTIVE ANALYSIS OF CML PATIENTS TREATED IN A SINGLE BRAZILIAN CANCER CENTER

EHA Library, Amanda Pifano Soares, 182544

PREDICTIVE PARAMETERS FOR IMATINIB FAILURE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Danijela Lekovic, 182545

A MULTICENTRE AUDIT OF SYMPTOMS AND QUALITY OF LIFE IN IRISH CML PATIENTS ON TYROSINE KINASE INHIBITORS

EHA Library, Jennifer Garry, 182546

COST-EFFECTIVENESS OF A THERAPEUTIC EDUCATION PROGRAM (TPE) FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AND TREATED BY TYROSINE KINASE INHIBITORS (TKI).

EHA Library, Marion Artur-Cordier, 182547

ROLE OF ALLO-HSCT IN THE TREATMENT OF PATIENTS WITH T315I MUTATION IN THE TKI ERA.

EHA Library, Yulia Vlasova, 182548

THYROID FUNCTIONAL STATUS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON TKIS - SINGLE -CENTER RESULTS

EHA Library, Marina Dragičević, 182549

RESPONSE RATES AND SURVIVAL OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA INITIALLY TREATED WITH IMATINIB: 11 YEAR EXPERIENCE OF A TEACHING HOSPITAL

EHA Library, Meghna Ruparelia, 182550

FRONT-LINE NILOTINIB IS A BETTER CHOICE THAN FRONT-LINE IMATINIB FOR CML PATIENTS WITH DELAYED TREATMENT: 11 YEAR FOLLOW-UP

EHA Library, Amina Kurtovic-Kozaric, 182551

THE INFLUENCE OF AGE ON TREATMENT OUTCOME OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA RECEIVING FRONTLINE IMATINIB

EHA Library, Cojbasic Irena, 182552

CHARACTERIZATION OF HEMATOPOIETIC SAMPLES FROM PYRUVATE KINASE DEFICIENCY PATIENTS

EHA Library, Rebeca Sanchez-Dominguez, 182553

OSMOTIC GRADIENT EKTACYTOMETRY: A VALUABLE SCREENING TEST FOR HEREDITARY SPHEROCYTOSIS AND OTHER RED BLOOD CELL MEMBRANE DISORDERS

EHA Library, MARIA DEL MAR MANU PEREIRA, 182554

RARE RED BLOOD CELL ENZYMOPATHIES INDUCED CHRONIC NONSPHEROCYTIC HEMOLYTIC ANEMIA: NEXT GENERATION SEQUENCING BASED MOLECULAR DIAGNOSIS

EHA Library, Manu Jamwal, 182555

COMPARISON STUDY OF THE EOSIN-5'-MALEIMIDE BINDING TEST, OSMOTIC FRAGILITY TEST ANDCRYOHEMOLYSIS TEST IN THE DIAGNOSIS OF HEREDITARY SPHEROCYTOSIS

EHA Library, Esin Özcan, 182556

ADVANCES IN DIAGNOSIS OF HEREDITARY HEMOLYTIC ANEMIAS: THERMOGRAVIMETRY COUPLED WITH CHEMOMETRICS

EHA Library, P. Caprari, 182557

DEVELOPMENT OF A POINT-SCORING SYSTEM FOR EARLY DIAGNOSTIC TESTING IN GAUCHER DISEASE: APPLICATION OF FINDINGS FROM THE GAUCHER EARLIER DIAGNOSIS CONSENSUS (GED-C) DELPHI INITIATIVE

EHA Library, Sam Salek, 182558

REGIONAL DISTRIBUTION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN TURKEY AND EVALUATION OF CLINICAL FINDINGS

EHA Library, Selim Sayin, 182559

CHARACTHERISTICS AND MANAGEMENT OF AUTOIMMUNE HEMOLYTIC ANEMIA : A SINGLE CENTER STUDY WITH 32 CASES

EHA Library, Hatice Demet Kiper, 182560

THE IMPACT OF THE REORGANIZATION OF THE PATIENT CARE PROCESS FOR GAUCHER DISEASE IN HEALTH SYSTEM.

EHA Library, Francisco Blanco-Favela, 182561

NORMOCYTIC ANEMIA IS MORE COMMON THAN MICROCYTIC ANEMIA IN GASTRO-INTESTINAL (GI) CANCERS: A LARGE SINGLE CENTRE STUDY

EHA Library, Floyd Lourenco, 182562

DEMONSTRATION OF FUNCTIONAL SIMILARITY OF PROPOSED BIOSIMILAR ABP 798 TO RITUXIMAB

EHA Library, Helen McBride, 182563

DELAYED EFFECT OF G-CSF ON THE CYTOKINE SECRETION THROUGH G-CSF MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS IN CHILDREN WITH CEREBRAL PALSY

EHA Library, Young-Ho Lee, 182564

MYD88 IN PRAME GENE ACTIVATION

EHA Library, Vsevolod Misyurin, 182565

PD-1 IS HIGHLY EXPRESSED ON MEMORY T-CELL SUBSETS RESIDING IN BONE MARROW BUT NOT IN PE-RIPHERAL BLOOD IN HEALTHY INDIVIDUALS.

EHA Library, Natalia Popova, 182566

BONE MARROW STROMAL CELLS MAY HAVE GENETIC ABERRATIONS AND ARE CAPABLE TO GAIN THEM IN A CULTURE.

EHA Library, Ildar Barkhatov, 182567

CIRCULATING ENDOTHELIAL PROGENITORS CELLS AND METABOLIC FACTORS IN CHILDHOOD CANCER SURVIVORS

EHA Library, Eftichia Stiakaki, 182568

HEMATOLOGICAL PARAMETERS IN NATIVE HIGHLANDERS OF LADAKH AGED 4-19 YEARS

EHA Library, Subrat Kumar Das, 182569

AGE VARIATION OF B-CELL PRECURSORS IN BONE MARROW: NORMAL VALUES AS A REFERENCE FOR MDS IN BRAZIL

EHA Library, Irene G. H. Lorand Metze, 182570

PERIOSTIN/BIGH3 RATIO AS A PROGNOSTIC MARKER OF IDIOPATHIC THROMBOCYTOPENIA AFTER ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION FOR THE PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

EHA Library, Yoo Jin Lee, 182571

ASSOCIATION WITH OMENN SYNDROME AND CYSTINURIA: CASE REPORT

EHA Library, Turkan Patıroglu, 182572

LABEL-FREE IMAGING BY AUTO-FLUORESCENCE PERMITS IDENTIFICATION OF ERYTHROID PRECURSORS IN BONE MARROW AND DETECTS CHANGES OF SOLUBILITY OF HEMOGLOBIN IN ERYTHROCYTES

EHA Library, Irene G. H. Lorand Metze, 182573

TWO HEMATOLOGICAL MALIGNANCIES, SIMULTANEOUS OR CONSECUTIVE OCCURRENCE. EXPERIENCE OF A CENTER.

EHA Library, Eleni Kapsali, 182574

B SYMPTOMS AND ELEVATED ESR AS PREDICTORS OF OVERALL SURVIVAL IN HODGKIN LYMPHOMA. A 20 YEAR FOLLOW UP MULTICENTER ANALYSIS.

EHA Library, Rolando O. Vallansot, 182575

ADVANCED HODGKIN LYMPHOMA PATIENTS WITHOUT LARGE TUMOR MASS - A NEW PROGNOSTIC SCORE IDENTIFIES PATIENTS WITH FAVORABLE OUTCOME

EHA Library, Bosko Andjelic, 182576

TREATMENT ESCALATION IN CASE OF POSITIVE PET 2 AND IMPACT OF EARLY PET IN EXTENSIVE STAGE HODGKIN LYMPHOMA.

EHA Library, Stéphanie Guidez, 182577

THE PROGNOSTIC IMPACT OF 18F-FDG PET/CT IN LYMPHOMA PATIENTS AFTER STANDARD CHEMOTHERAPY

EHA Library, Branimir Spassov, 182578

BCL-2 AND CD30 EXPRESSION IN HODGKIN AND REED-STERNBERG CELLS OF CLASSICAL HODGKIN'S LYMPHOMA AS A POORER PROGNOSIS CRITERIA

EHA Library, Anatolij Rukavitcyn, 182579